Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.40% Nasdaq Up0.97%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.48 0.20(6.10%) Apr 22, 4:00PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 22, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 22, 2014New Constructs, LLCN/ACYCC: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 18, 2014S&P Capital IQ Quantitative ReportN/ACyclacel Pharmaceuticals11$126.50
Apr 18, 2014Pechala's ReportsFrantisek PechalaCYCLACEL PHARMACEUTICALS INC (CYCC) 12-months forecast1$15
Apr 16, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ALSE , CVM , CHTP , CYCC , CUR , OXBT -- DRUGS3$34.50
Apr 16, 2014Ford Investor Services, Inc.N/AValue Graph: CYCLACEL PHARMAC -- CYCC1$11.50
Apr 15, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Cyclacel Pharmaceuticals, Inc.42$75
Apr 13, 2014Laidlaw & CompanyMr. Edward WhiteCyclacel Pharmaceuticals (CYCC) Update Post-Secondary Offering; Maintaining Buy-rating and $10 Price Target8$25
Apr 12, 2014TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CYCLACEL PHARMACEUTICALS (CYCC)5$10
Apr 5, 2014TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CYCLACEL PHARMACEUTICALS (CYCC)5$10

View All Reports for CYCC ...